Indian drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) had put a partial clinical hold on its application for an experimental dermatological drug due to the potential of thrombotic events.
Indian drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) had put a partial clinical hold on its application for an experimental dermatological drug due to the potential of thrombotic events. Indian drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) had put a partial clinical hold on its application for an experimental dermatological drug due to the potential of thrombotic events. Moneycontrol Latest News Read More
English 
हिन्दी